## AZO: AutoZone, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -6.1% below STRENGTH zone (4.0-10.0%); PEG 1.78 fails VALUE criteria (<1.0); RSI 25 oversold (REVERSION excluded per A/B test). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($3098.63)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. These Catalysts Could Drive AutoZone Stock Higher in 2026**
- Source: Finviz | 20260106T120741 | Somewhat-Bullish | Relevance: 100%
- AutoZone stock experienced a sharp drop in late 2025 due to narrowing profit margins but continues to grow, particularly through international expansion in the Americas. The company's aggressive store opening strategy and strong comparable sales growth in international markets are seen as key catalysts for future increased sales and earnings. While there are no current plans for European expansion, sustained growth in the Americas could eventually lead to new market exploration, presenting an attractive long-term buying opportunity.

**2. Robeco Institutional Asset Management B.V. Sells 521 Shares of AutoZone, Inc. $AZO**
- Source: MarketBeat | 20260106T115956 | Somewhat-Bearish | Relevance: 100%
- Robeco Institutional Asset Management B.V. reduced its stake in AutoZone, Inc. by 0.7% in the third quarter, selling 521 shares. Despite this, other hedge funds significantly increased their positions in AZO, with institutional investors now owning 92.74% of the stock. Analyst ratings maintain a "Moderate Buy" consensus for AutoZone, which reported revenue up 8.2% year-over-year but missed EPS estimates for the last quarter.

**3. AutoZone, Inc. (NYSE:AZO) Receives Average Recommendation of "Moderate Buy" from Brokerages**
- Source: MarketBeat | 20260105T080808 | Somewhat-Bullish | Relevance: 100%
- AutoZone, Inc. (NYSE:AZO) has received an average "Moderate Buy" rating from 32 brokerages, with a consensus 12-month price target of $4,342.84, representing a 31% upside from its current price. Despite missing recent quarterly earnings and revenue estimates, the company's revenue increased by 8.2% year-over-year. Insider transactions show both sales and purchases, and institutional ownership remains high at 92.74%.

**4. Earl Graves Jr Sells 250 Shares of AutoZone (NYSE:AZO) Stock**
- Source: MarketBeat | 20260106T001931 | Somewhat-Bearish | Relevance: 99%
- Earl Graves Jr, a director at AutoZone, recently sold 250 shares of the company's stock for over $823,000, reducing his stake by 4.87%. This transaction comes as AutoZone's shares traded down following a miss on quarterly EPS expectations, despite revenue being largely in line. Analysts currently maintain a "Moderate Buy" rating for AZO with a target price of $4,330.84.

**5. The Truth About Genuine Parts Co: Why Wall Street Sleepers Might Be Missing This Quiet Beast**
- Source: AD HOC NEWS | 20260106T104049 | Somewhat-Bullish | Relevance: 88%
- This article champions Genuine Parts Co (GPC), a seemingly boring auto and industrial parts giant, as a potential overlooked investment for long-term, income-focused investors. It highlights GPC's stable cash flow, consistent dividend payouts, and diversified business model as key strengths, contrasting it with more volatile "hype" stocks like AutoZone. The author suggests GPC is a "quiet winner" ideal for those seeking steady portfolio growth rather than quick flips.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 12)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-05 | Mizuho | $3550 | $3850 | -8% |
| 2025-12-18 | JP Morgan | $4100 | $4850 | -15% |
| 2025-12-16 | Wolfe Research | $0 | $0 | 0% |
| 2025-12-11 | Citigroup | $4200 | $4775 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-05 | Mizuho | down | Neutral |
| 2025-12-18 | JP Morgan | main | Overweight |
| 2025-12-16 | Wolfe Research | down | Peer Perform |
| 2025-12-11 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 20 ($1.93M) |
| Sells | 6 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.9% (+1.5%)
- Blackrock Inc.: 7.7% (-0.2%)
- JPMORGAN CHASE & CO: 6.4% (+68.9%)
- State Street Corpora: 4.3% (+0.1%)
- Geode Capital Manage: 2.7% (+1.0%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.2% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 15.0% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.78 elevated, pricing in significant growth expectations. Forward P/E 18.5x attractive for 19% earnings growth. Quality metrics strong (ROA 12%). Analyst sentiment negative (12 target cuts vs 0 raises). Insider buying signal ($1.9M), management confidence. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $54.0B |
| Beta | 0.42 |
| 52W Range | $3162.00 - $4388.11 |
| Short Interest | 2.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.78 |
| Forward P/E | 18.5 |
| Current P/E | 22.0 |
| YoY Growth | 19.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -3.9% to -6.1% (-2.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 10.1pp (needs >4.0% for momentum thesis). AM_20 at -5.4% indicates price below own 20MA trend. Underperforming sector by 5.7pp, stock-specific weakness. Below SMA200 (0.85x), long-term trend not supportive. MACD histogram bearish (-7.79), momentum weakening. RSI oversold at 25, potential bounce setup. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -6.11% (CS: 4) | Weak |
| RSI_14 | 24.7 | Oversold |
| MACD Histogram | -7.79 | Bearish |
| vs SMA20 | 0.946x | Below |
| vs SMA50 | 0.888x | Below |
| vs SMA200 | 0.850x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $3242.23
- **Stop Loss:** $3098.63 (4.4% risk)
- **Target:** $3385.83 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 7
- **Position Value:** $22,695.61
- **Portfolio %:** 22.70%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | RISK_ON (MEDIUM) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*RISK_ON regime with strong participation and low volatility. VIX at 14.75 (6th percentile) with breadth at 63.5% signals healthy risk appetite. Fed dovish expectations and AI/semiconductor momentum are primary drivers, though elevated put/call ratio suggests smart money hedging. Focus on quality growth with awareness of potential complacency.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $32.35 | $31.04 | -4.0% |
| 2025Q3 | $50.68 | $48.71 | -3.9% |
| 2025Q2 | $37.01 | $35.36 | -4.5% |
| 2025Q1 | $28.97 | $28.29 | -2.4% |

---
*RULE-based L3 | 2026-01-07 08:25 | MRS_20*